Safety and immunogenicity of a novel oral hexavalent rotavirus vaccine：a phase I clinical trial

• প্রধান লেখক: Zhi-Wei Wu (লেখক), Qing-Liang Li (লেখক), Hai-Song Zhou (লেখক), Kai Duan (লেখক), Zhao Gao (লেখক), Xin-Jiang Zhang (লেখক), Zhi-Jun Jiang (লেখক), Zhi-Yong Hao (লেখক), Fei Jin (লেখক), Xuan Bai (লেখক), Qi Li (লেখক), Ge-Lin Xu (লেখক), Yu-Liang Zhao (লেখক), Xiao-Ming Yang (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Taylor & Francis Group, 2021-07-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Background Rotavirus infections, prevalent in human populations, are caused mostly by group A viruses. Immunization against rotaviruses in infancy is currently the most effective and economical strategy to prevent rotavirus infection. This study evaluated the safety of a novel hexavalent rotavirus v...